Lataa...
Next-Generation Immunotherapies to Improve Anticancer Immunity
Checkpoint inhibitors are widely used immunotherapies for advanced cancer. Nonetheless, checkpoint inhibitors have a relatively low response rate, work in a limited range of cancers, and have some unignorable side effects. Checkpoint inhibitors aim to reinvigorate exhausted or suppressed T cells in...
Tallennettuna:
| Julkaisussa: | Front Pharmacol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7831045/ https://ncbi.nlm.nih.gov/pubmed/33505304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.566401 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|